Intellia Therapeutics Inc buy Truist Financial Co.
Start price
10.11.25
/
50%
€8.65
Target price
10.11.26
€12.11
Performance (%)
43.01%
Price
23.01.26
€12.37
Summary
This prediction is currently active. With a performance of 43.01% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 10.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 14.863% | 14.863% |
| iShares Core DAX® | -1.764% | 2.259% |
| iShares Nasdaq 100 | -1.632% | -0.193% |
| iShares Nikkei 225® | -2.451% | 4.086% |
| iShares S&P 500 | -2.252% | -0.151% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $14.00 price target on the stock, down previously from $25.00.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.43
04.03.25
04.03.25
€47.44
04.03.26
04.03.26
46.64%
23.01.26
23.01.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€111.85
24.06.25
24.06.25
-64.98%
25.06.25
25.06.25